“After a decade of experience with microarrays, our group researched all of the available next-gen platforms, and concluded that the Helicos SMS™ technology provided the broadest unbiased coverage of the transcriptome. Our results on the human blood transcriptome in various disease states using SeqLL’s RNAseq platform are nothing short of stunning. The breadth, depth and reproducibility of the transcript profiling is unprecedented. We’re seeing everything from microRNAs, coding transcripts, splice variants, coding SNPs and non-coding RNAs all in one view, which gives us completely new avenues for RNA-based diagnostics.”
Tim McCaffrey, Ph.D.
Director, Division of Genomic Medicine
The George Washington University Medical Center

“Thank you, SeqLL, for continuing your outstanding support of our research by providing the best in sequencing services. As our recent publications attest, we have found that no other technology can match Helicos SMS™ for high quality publishable RNAseq findings. In addition, we appreciate the attention to detail and responsiveness that your organization provides…”
St. Laurent Institute Georges
St. Laurent, III,
Scientific Director